Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02210507 · ClinicalTrials.gov registry record · NA
Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari
A NA study of Vitamin A Deficiency, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02210507: Completed NA study of Vitamin A Deficiency, sponsored by USDA, Western Human Nutrition Research Center.
NCT02210507 is a NA study of Vitamin A Deficiency that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02210507, a NA study of Vitamin A Deficiency, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the research study is to determine the absorption, metabolism, and bioconversion of carotenoids such as beta-carotene to vitamin A from gari made with biofortified cassava compared to a mixture of red palm oil and gari made from typical white cassava.
Primary Outcome
Vitamin A is measured by standard methods involving ultracentrifugation (to concentrate the TRL fraction) followed by reversed-phase high pressure liquid chromatography (HPLC) using electrochemical detection.
Conditions Studied
Interventions
- OTHER Biofortified cassava gari
- OTHER White cassava gari
- OTHER White cassava gari + red palm oil
Study Locations (1)
California
- USDA, ARS, Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT02210507 record still lists
NCT02210507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vitamin A Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Biofortified cassava gari is the first listed.
NCT02210507 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02210507 about?
NCT02210507 is a clinical study titled "Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari". The goal of the research study is to determine the absorption, metabolism, and bioconversion of carotenoids such as beta-carotene to vitamin A from gari made with biofortified cassava compared to a mixture of red palm oil and gari made from typical white cassava.
What is the current status of trial NCT02210507?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-07. Estimated completion is 2014-12.
What conditions does trial NCT02210507 study?
This clinical trial studies the following conditions: Vitamin A Deficiency.
What interventions are being tested in trial NCT02210507?
The interventions under investigation include: Biofortified cassava gari (OTHER), White cassava gari (OTHER), White cassava gari + red palm oil (OTHER).
Who is sponsoring clinical trial NCT02210507?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02210507 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin A Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02210507's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia